Repligen Corporation

Repligen Corporation is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Repligen Corporation is not a good value stock. Repligen Corporation is not very popular among insiders. Repligen Corporation is a mediocre stock to choose.
Log in to see more information.
Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of man...
RGEN Fundamental Data by TradingView

News

Analysts Set Repligen Co. (NASDAQ:RGEN) Target Price at $188.38
Analysts Set Repligen Co. (NASDAQ:RGEN) Target Price at $188.38

Zolmax Shares of Repligen Co. (NASDAQ:RGEN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the ten research firms that are currently covering the firm, Marketbeat Ratings...\n more…

Several Headwinds Dragged Repligen Corporation (RGEN) in Q2
Several Headwinds Dragged Repligen Corporation (RGEN) in Q2

Insider Monkey Columbia Acorn Fund, distributed by Columbia Management Investment Distributors, released its second quarter 2024 investor letter. A copy of the fund can be downloaded here. In the quarter, the fund...\n more…

TD Asset Management Inc Has $7.43 Million Stock Position in Repligen Co. (NASDAQ:RGEN)
TD Asset Management Inc Has $7.43 Million Stock Position in Repligen Co. (NASDAQ:RGEN)

Ticker Report TD Asset Management Inc boosted its position in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 2.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange...\n more…

Norden Group LLC Boosts Stock Position in Repligen Co. (NASDAQ:RGEN)
Norden Group LLC Boosts Stock Position in Repligen Co. (NASDAQ:RGEN)

Ticker Report Norden Group LLC boosted its holdings in shares of Repligen Co. (NASDAQ:RGEN - Free Report) by 32.2% during the second quarter, according to the company in its most recent filing with the Securities...\n more…

Rhumbline Advisers Sells 6,175 Shares of Repligen Co. (NASDAQ:RGEN)
Rhumbline Advisers Sells 6,175 Shares of Repligen Co. (NASDAQ:RGEN)

Zolmax Rhumbline Advisers reduced its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 3.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund...\n more…

Rhumbline Advisers Lowers Holdings in Repligen Co. (NASDAQ:RGEN)
Rhumbline Advisers Lowers Holdings in Repligen Co. (NASDAQ:RGEN)

Ticker Report Rhumbline Advisers trimmed its stake in Repligen Co. (NASDAQ:RGEN - Free Report) by 3.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission...\n more…